256 related articles for article (PubMed ID: 8187346)
21. Anti-CD38-blocked ricin: an immunotoxin for the treatment of multiple myeloma.
Goldmacher VS; Bourret LA; Levine BA; Rasmussen RA; Pourshadi M; Lambert JM; Anderson KC
Blood; 1994 Nov; 84(9):3017-25. PubMed ID: 7524764
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a monoclonal antibody having selective reactivity with normal and neoplastic plasma cells.
Tong AW; Lee JC; Stone MJ
Blood; 1987 Jan; 69(1):238-45. PubMed ID: 3098320
[TBL] [Abstract][Full Text] [Related]
23. C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.
Kraj M; Pogłód R; Kopeć-Szlezak J; Sokołowska U; Woźniak J; Kruk B
Leuk Lymphoma; 2004 Nov; 45(11):2281-9. PubMed ID: 15512818
[TBL] [Abstract][Full Text] [Related]
24. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
[TBL] [Abstract][Full Text] [Related]
25. An antigenic study of human plasma cells in normal tissue and in myeloma: identification of a novel plasma cell associated antigen.
Nathan PD; Walker L; Hardie D; Richardson P; Khan M; Johnson GD; Ling NR
Clin Exp Immunol; 1986 Jul; 65(1):112-9. PubMed ID: 3024883
[TBL] [Abstract][Full Text] [Related]
26. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry.
Terstappen LW; Johnsen S; Segers-Nolten IM; Loken MR
Blood; 1990 Nov; 76(9):1739-47. PubMed ID: 2224123
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
[TBL] [Abstract][Full Text] [Related]
29. Establishment of a CD45-positive immature plasma cell line from an aggressive multiple myeloma with high serum lactate dehydrogenase.
Hata H; Matsuzaki H; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
Leukemia; 1994 Oct; 8(10):1768-73. PubMed ID: 7934174
[TBL] [Abstract][Full Text] [Related]
30. Cell surface markers in multiple myeloma.
Ruiz-Argüelles GJ; San Miguel JF
Mayo Clin Proc; 1994 Jul; 69(7):684-90. PubMed ID: 8015335
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
32. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
33. [Detection of myeloma cells in peripheral blood using multi-parameter flow cytometry: monitoring residual disease].
Klabusay M; Doubek M; Adam Z; Hájek R; Krivanová A
Cas Lek Cesk; 2000 Jul; 139(14):432-6. PubMed ID: 11048405
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders.
Witzig TE; Meyers C; Therneau T; Greipp PR
Leuk Lymphoma; 2000 Jul; 38(3-4):345-50. PubMed ID: 10830741
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.
Pellat-Deceunynck C; Bataille R; Robillard N; Harousseau JL; Rapp MJ; Juge-Morineau N; Wijdenes J; Amiot M
Blood; 1994 Oct; 84(8):2597-603. PubMed ID: 7522634
[TBL] [Abstract][Full Text] [Related]
36. [Detection of myeloma cells in the peripheral blood using flow cytometry].
Adam Z; Klabusay M; Vorlícek J; Hájek R
Vnitr Lek; 1997 Sep; 43(9):592-8. PubMed ID: 9750468
[TBL] [Abstract][Full Text] [Related]
37. The clonal hierachy in multiple myeloma.
Rasmussen T; Jensen L; Johnsen HE
Acta Oncol; 2000; 39(7):765-70. PubMed ID: 11145430
[TBL] [Abstract][Full Text] [Related]
38. IgD myeloma presenting as a testicular tumor: establishment and characterization of an IgD-secreting myeloma cell line.
Ishii K; Yamato K; Kubonishi I; Taguchi H; Ohtsuki Y; Miyoshi I
Am J Hematol; 1992 Nov; 41(3):218-24. PubMed ID: 1329502
[TBL] [Abstract][Full Text] [Related]
39. Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells.
Oliver AM; Martin F; Kearney JF
J Immunol; 1997 Feb; 158(3):1108-15. PubMed ID: 9013949
[TBL] [Abstract][Full Text] [Related]
40. Detection of myeloma cells in the peripheral blood by flow cytometry.
Witzig TE; Kimlinger TK; Ahmann GJ; Katzmann JA; Greipp PR
Cytometry; 1996 Jun; 26(2):113-20. PubMed ID: 8817086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]